[go: up one dir, main page]

RU2004124844A - Прукалоприд-n-оксид - Google Patents

Прукалоприд-n-оксид Download PDF

Info

Publication number
RU2004124844A
RU2004124844A RU2004124844/04A RU2004124844A RU2004124844A RU 2004124844 A RU2004124844 A RU 2004124844A RU 2004124844/04 A RU2004124844/04 A RU 2004124844/04A RU 2004124844 A RU2004124844 A RU 2004124844A RU 2004124844 A RU2004124844 A RU 2004124844A
Authority
RU
Russia
Prior art keywords
compound
compound according
formula
pharmaceutically acceptable
pharmaceutical composition
Prior art date
Application number
RU2004124844/04A
Other languages
English (en)
Other versions
RU2301806C2 (ru
Inventor
Йоаннес Адрианус Якобус СХУРКЕС (BE)
Йоаннес Адрианус Якобус СХУРКЕС
ЛАЕРХОВЕН Вилли Йоаннес Каролус ВАН (BE)
ЛАЕРХОВЕН Вилли Йоаннес Каролус ВАН
Original Assignee
Янссен Фармацевтика Н.В. (Be)
Янссен Фармацевтика Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Янссен Фармацевтика Н.В. (Be), Янссен Фармацевтика Н.В. filed Critical Янссен Фармацевтика Н.В. (Be)
Publication of RU2004124844A publication Critical patent/RU2004124844A/ru
Application granted granted Critical
Publication of RU2301806C2 publication Critical patent/RU2301806C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Claims (8)

1. Соединение формулы (I)
Figure 00000001
и его стереохимически изомерные формы и фармацевтически приемлемые кислотно-аддитивные соли.
2. Соединение по п.1, имеющее цис-конфигурацию.
3. Соединение по п.1, имеющее транс-конфигурацию.
4. Соединение по любому из пп.1-3, где соединение формулы (I) представляет собой (1:1) гидрат.
5. Фармацевтическая композиция, содержащая фармацевтически приемлемый носитель и терапевтически активное количество соединения по любому из пп.1-4.
6. Способ получения фармацевтической композиции по п.5, где терапевтически активное количество соединения по любому из пп.1-4 однородно смешивают с фармацевтически приемлемым носителем.
7. Соединение по любому из пп.1-4 для применения в качестве лекарственного средства.
8. Способ получения соединения формулы (I) путем окисления соединения формулы (II) подходящими окислителями в реакционно-инертном растворителе.
Figure 00000002
RU2004124844/04A 2002-01-16 2003-01-13 Прукалоприд-n-оксид RU2301806C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02075157 2002-01-16
EP02075157.4 2004-01-16

Publications (2)

Publication Number Publication Date
RU2004124844A true RU2004124844A (ru) 2006-01-20
RU2301806C2 RU2301806C2 (ru) 2007-06-27

Family

ID=8185531

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2004124844/04A RU2301806C2 (ru) 2002-01-16 2003-01-13 Прукалоприд-n-оксид

Country Status (18)

Country Link
US (2) US20050085510A1 (ru)
EP (1) EP1467991B1 (ru)
JP (1) JP2005514458A (ru)
KR (1) KR101023433B1 (ru)
CN (1) CN1330646C (ru)
AT (1) ATE295845T1 (ru)
AU (1) AU2003206722B2 (ru)
CA (1) CA2471729C (ru)
DE (1) DE60300683T2 (ru)
ES (1) ES2242940T3 (ru)
IL (1) IL163025A (ru)
MX (1) MXPA04006888A (ru)
NO (1) NO326580B1 (ru)
NZ (1) NZ533041A (ru)
PL (1) PL214274B1 (ru)
RU (1) RU2301806C2 (ru)
WO (1) WO2003059906A1 (ru)
ZA (1) ZA200405654B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR058022A1 (es) * 2005-08-22 2008-01-23 Solvay Pharm Bv Derivados de benzooxazoles, composiciones farmaceuticas y su uso para el tratamiento de desordenes del sistema nervioso.
US7750013B2 (en) 2005-08-22 2010-07-06 Solvay Pharmaceuticals, B.V. N-oxides as prodrugs of piperazine and piperidine derivatives
EP1919883B1 (en) * 2005-08-22 2008-12-17 Solvay Pharmaceuticals B.V. N-oxides as prodrugs of piperazine&piperidine derivatives
US20070294778A1 (en) * 2006-03-16 2007-12-20 Adam Rich Zebrafish model for assessing gastrointestinal motility
WO2017137910A1 (en) 2016-02-11 2017-08-17 Symed Labs Limited Processes for the preparation of highly pure prucalopride succinate and its intermediates
CN112500398A (zh) * 2020-12-24 2021-03-16 艾希尔（深圳）药物研发有限公司 一种普鲁卡必利氧化物的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8716587D0 (en) * 1987-07-14 1987-08-19 Shell Int Research Preparing thiophene derivatives
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) * 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
CZ289031B6 (cs) * 1994-09-27 2001-10-17 Janssen Pharmaceutica N. V. Deriváty N-substituovaných piperidinylových bicyklických benzoátů
TW490465B (en) * 1994-11-24 2002-06-11 Janssen Pharmaceutica Nv Enterokinetic benzamide, the preparation process and the pharmaceutical compositions thereof
TW382017B (en) * 1995-12-27 2000-02-11 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives
NZ330263A (en) * 1996-02-15 1999-06-29 Janssen Pharmaceutica Nv Esters of 3-hydroxy-piperidinemethanol derivatives to improve gastric emptying
TW445263B (en) * 1996-02-29 2001-07-11 Janssen Pharmaceutica Nv Novel esters of 1,4-disubstituted piperidine derivatives
CA2352278A1 (en) * 1998-11-23 2000-06-02 Janssen Pharmaceutica, N.V. Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia
TW592709B (en) * 1999-04-29 2004-06-21 Janssen Pharmaceutica Nv Prucalopride oral solution

Also Published As

Publication number Publication date
EP1467991B1 (en) 2005-05-18
DE60300683T2 (de) 2006-04-27
ZA200405654B (en) 2005-09-28
ES2242940T3 (es) 2005-11-16
CA2471729C (en) 2010-03-23
US20080125464A1 (en) 2008-05-29
KR101023433B1 (ko) 2011-03-25
AU2003206722B2 (en) 2008-01-24
CN1330646C (zh) 2007-08-08
JP2005514458A (ja) 2005-05-19
DE60300683D1 (de) 2005-06-23
ATE295845T1 (de) 2005-06-15
RU2301806C2 (ru) 2007-06-27
EP1467991A1 (en) 2004-10-20
NO326580B1 (no) 2009-01-12
NZ533041A (en) 2006-04-28
HK1075894A1 (zh) 2005-12-30
CN1615308A (zh) 2005-05-11
PL370379A1 (pl) 2005-05-16
US8063069B2 (en) 2011-11-22
KR20040074981A (ko) 2004-08-26
NO20043397L (no) 2004-08-16
AU2003206722A1 (en) 2003-07-30
WO2003059906A1 (en) 2003-07-24
IL163025A (en) 2010-06-16
CA2471729A1 (en) 2003-07-24
US20050085510A1 (en) 2005-04-21
PL214274B1 (pl) 2013-07-31
MXPA04006888A (es) 2004-12-06

Similar Documents

Publication Publication Date Title
PE20040164A1 (es) Mimeticos de glucocorticoides, procedimientos para su preparacion y composiciones farmaceuticas
UY27368A1 (es) Nuevos compuestos
AP1635A (en) Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease.
JP2003535843A5 (ru)
PE20060352A1 (es) Compuestos de aril- o heteroarilamida ortosustituidos
CY1112800T1 (el) Η χρηση υποκαθιστουμενων κυανοπυρρολιδινων για τη θεραπεια της υπερλιπιδαιμιας
PH25504A (en) Novel substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides pharmaceutical composition containing said compound, method of use thereof
JP2005511698A5 (ru)
PE20231746A1 (es) Compuestos de union a cereblon, composiciones de estos y metodos de tratamiento con estos
RU2004124844A (ru) Прукалоприд-n-оксид
DE60331051D1 (de) Neue atorvastatinsalze und pharmazeutische zusammensetzungen, die diese enthalten
RU2007132179A (ru) Ингибирующие вич производные 2-(4-цианофениламино)пиримидина
JP2004538278A5 (ru)
HU212494B (en) Process for producing new tetraline derivatives and pharmaceutical compositions containing them as active components
DE60318716D1 (de) Thieno-pyrrole verbindungen als antagonisten der gonadotropin-freisetzenden hormonrezeptoren
RU2003126176A (ru) Кислотно-аддитивные соли тербинафина и яблочной кислоты
KR900009596A (ko) N-피리디닐-9h-카바졸-9-아민, 이의 제조방법 및 이의 약제로서의 용도
RU2007136782A (ru) Ингибирующие вич 2-(4-цианофенил)-6-гидроксиламинопиримидины
RU2009106073A (ru) (s)-(-)-амлодипина камзилат или его гидрат и фармацевтическая композиция, включающая их
KR960029319A (ko) 4-아미노벤조일구아니딘 유도체
RU2005123328A (ru) Оксазолы в качестве усилителей mgiuri
CA2355716A1 (en) Benzisoxazoles and phenones as .alpha.2-antagonists
BG106846A (en) Novel heteroaryl derivatives, their preparation and use
GB0116577D0 (en) Succinic acid derivatives
CN1370145A (zh) 新的方法